TY  - JOUR
T1  - PRoton pump inhibitors linked to fracture risk
AU  - Voelker R
Y1  - 2010/07/07
N1  - 10.1001/jama.2010.862
JO  - JAMA
SP  - 29
EP  - 29
VL  - 304
IS  - 1
N2  - 
The FDA's decision to add new precautionary information to PPI labeling is based on data from 7 epidemiological studies published since 2006. Six of the 7 showed a relationship between PPI use and an increased risk of fractures. Most of the patients in the studies were aged 50 years or older; the increased risk of fracture was seen primarily in this group.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2010.862
UR  - http://dx.doi.org/10.1001/jama.2010.862
ER  -